Overview
Effect of "Sekanjabin e Safarjali" (Quince Oxymel) in the Prevention of Migraine Attacks
Status:
Unknown status
Unknown status
Trial end date:
2014-10-01
2014-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine whether Quince Oxymel is effective in the prevention of Migraine attacks in patients with simultaneous upper gastrointestinal dysfunction.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Shiraz University of Medical SciencesTreatments:
Propranolol
Criteria
Inclusion Criteria:- minimum age of 18 years old
- giving a written informed consent
- having at least 2 migraine attacks per month
Exclusion Criteria:
- patients older than 70 years old
- patients with Diabetes mellitus
- patients with chronic obstructive pulmonary disease and asthma
- pregnancy
- severe depression
- patients affected by sexual disorders
- bradyarrhythmic patients
- positive history of hypersensitivity reactions to quince, ginger, propranolol or
naproxen